Skip to content

Dexmedetomidine for Prophylaxis Against PONV in Highly Susceptible Patients.

Dexmedetomidine for Prophylaxis Against Postoperative Nausea and Vomiting in Highly Susceptible Patients: a Randomised Controlled Comparison of Two Bolus Doses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05134363
Enrollment
180
Registered
2021-11-24
Start date
2021-08-11
Completion date
2023-06-20
Last updated
2023-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Surgeries, Postoperative Nausea and Vomiting

Keywords

Dexmedetomidine, PONV, ondansetron, post operative, nausea, vomiting

Brief summary

The study aims to compare between two bolus doses of dexmedetomidine in preventing PONV in highly susceptible patients.

Detailed description

Being A challenging complaint, many studies tried to find an effective preventive strategies for PONV. In this study protocol the investigators aim to compare between 0.5 mic/kg and 0.75 mic/kg bolus doses of dexmedetomidine when given toward the end of head and neck surgeries in highly susceptible patients with a controlled group receiving ondansetron. The primary outcome is the 1st 24 hours incidence of PONV Other outcomes include: * Time to 1st call for rescue antiemetic and the total amount of antiemetics * Number of PONV attacks * Post operative pain score with visual analogous scale (VAS) and time to 1st call for rescue analgesia * Sedation Score using Observer's Assessment of Alertness and sedation (OAA/S) * Patient satisfaction * Vital signs in the 1st 24 hours

Interventions

DRUGDexmedetomidine Hydrochloride 0.5 mic/kg bolus

comparison between two bolus doses of dexmedetomidine with a placebo group

DRUGDexmedetomidine Hydrochloride 0.75 mic/kg bolus

comparison between two bolus doses of dexmedetomidine with a conventional group receiving ondansetron.

DRUGPlacebo

equal volume of normal saline

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Intervention model description

comparative study between two doses and a 3rd control group

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Two risk factors or more for PONV ( female, non-smoking, postoperative opioids, history of motion sickness or PONV ) * Head and neck surgeries in adults * ASA ( I , II )

Exclusion criteria

* Patients on ( steroids , antiemetics or any drug caude emesis ) * Any active cardiac condition at the time of the surgery * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Incidence of PONV in the 1st 24 hours postoperativelyThe first 24 hours ( every half an hour in the 1st 2 hours and then at 4,6,8,12 and 24 hours )The overall incidence of nausea and vomiting in the 1st 24 hours following Head and neck surgeries.

Secondary

MeasureTime frameDescription
Pain score postoperatively.The first24 hours ( every half an hour in the 1st 2 hours and then at 4,6,8,12 and 24 hours )Pain assessement using visual analogous scale score (0-10) with 10 denoting the worst pain expressed and zero= no pain
Sedation scoreThe first24 hours ( every half an hour in the 1st 2 hours and then at 4,6,8,12 and 24 hours )using Observer's assessment of ALERTNESS and Sedation (1-5)with 1 = unconscious and 5= Alert
Patient satisfactionThe first24 hours ( every half an hour in the 1st 2 hours and then at 4,6,8,12 and 24 hours )The patient completes a simple questionnaire with 0= very satisfied 1 = satisfied 2= not satisfied
Blood pressureThe first24 hours ( every half an hour in the 1st 2 hours and then at 4,6,8,12 and 24 hours )Mean arterial blood pressure (MAP) in the 1st 24 hours
Number of PONV attacksThe first24 hours ( every half an hour in the 1st 2 hours and then at 4,6,8,12 and 24 hours )Number of PONV attacks in the 1st 24 hours following Head and neck surgeries
The time to 1st call for rescue antiemeticIn the 1st 24 hourstime to 1st call for rescue antiemetic and the severity of nausea ( using the 11 verbal 11-point rating scale 0= no nausea 10= the worst nausea
The severity of nausea.The first24 hours ( every half an hour in the 1st 2 hours and then at 4,6,8,12 and 24 hours )the severity of nausea ( using the 11 verbal 11-point rating scale 0= no nausea 10= the worst nausea
Total amount of morphine consumptionThe first24 hours ( every half an hour in the 1st 2 hours and then at 4,6,8,12 and 24 hours )morphine consumed in thw 1st 24 hours in milligrams.
The time to 1st call for rescue analgesiaIn the first 24 hourstime to 1st call for rescure analgesic medication in the 1st 24 hours postoperatively
Heart Rate (HR)The first24 hours ( every half an hour in the 1st 2 hours and then at 4,6,8,12 and 24 hours )Pulse rate in the 1st 24 hours

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026